Enhancer ID: | E_01_0982 |
Species: | human |
Position : | chr18:79393019-79395019 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Myasthenia gravis |
Pubmed ID: | 32153563 |
Enhancer experiment: | ELISAs |
Enhancer experiment description: | We also found binding sites for nuclear factor of activated T-cells (NFATC1), nuclear factor kappa-light-chain_x0002_enhancer of activated B cells (NF-?B), early growth response factor (EGR1), and the estrogen receptor 1 (ESR1). |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | We also found binding sites for nuclear factor of activated T-cells (NFATC1), nuclear factor kappa-light-chain_x0002_enhancer of activated B cells (NF-?B), early growth response factor (EGR1), and the estrogen receptor 1 (ESR1). |
TF name : | NFATC1(NF-ATC,NF-ATc1.2,NFAT2,NFATc) |
TF experiment: | ?????? |
TF experiment description: | We also found binding sites for nuclear factor of activated T-cells (NFATC1), nuclear factor kappa-light-chain_x0002_enhancer of activated B cells (NF-?B), early growth response factor (EGR1), and the estrogen receptor 1 (ESR1). |
Enhancer function : | We also found binding sites for nuclear factor of activated T-cells (NFATC1), nuclear factor kappa-light-chain_x0002_enhancer of activated B cells (NF-?B), early growth response factor (EGR1), and the estrogen receptor 1 (ESR1). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
We also found binding sites for nuclear factor of activated T-cells (NFATC1), nuclear factor kappa-light-chain_x0002_enhancer of activated B cells (NF-?B), early growth response factor (EGR1), and the estrogen receptor 1 (ESR1). |
SNP ID: | -- |